U.S. Markets closed

Incyte Earnings, Revenue Beat in Q1

Investing.com - Incyte (NASDAQ:INCY) reported first quarter earnings that Beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $0.62 on revenue of $497.9M. Analysts polled by Investing.com expected EPS of $0.31 on revenue of $490.12M. That compared to EPS of $-0.19 on revenue of $382.28M in the same period a year earlier. The company had reported EPS of $0.32 on revenue of $528.4M in the previous quarter.


Incyte follows other major Healthcare sector earnings this month


On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.

Pfizer earnings Beat analysts' expectations on Tuesday, with first quarter EPS of $0.85 on revenue of $13.12B. Investing.com analysts expected EPS of $0.75 on revenue of $13B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Merck's first-quarter profit beats on Keytruda boost

Cable operator Charter edges past quarterly revenue estimates

Pfizer posts earnings beat, raises 2019 profit forecast